When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data.
about
When Enough Is Enough: Decision Criteria for Moving a Known Drug into Clinical Testing for a New Indication in the Absence of Preclinical Efficacy Data.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
When Enough Is Enough: Decisio ...... of Preclinical Efficacy Data.
@en
When Enough Is Enough: Decisio ...... of Preclinical Efficacy Data.
@nl
type
label
When Enough Is Enough: Decisio ...... of Preclinical Efficacy Data.
@en
When Enough Is Enough: Decisio ...... of Preclinical Efficacy Data.
@nl
prefLabel
When Enough Is Enough: Decisio ...... of Preclinical Efficacy Data.
@en
When Enough Is Enough: Decisio ...... of Preclinical Efficacy Data.
@nl
P2093
P2860
P50
P356
P1476
When Enough Is Enough: Decisio ...... of Preclinical Efficacy Data.
@en
P2093
David A Edwards
Gordon R Bernard
Helen M Naylor
Jana K Shirey-Rice
Jill M Pulley
Kenneth J Holroyd
Laura L Dugan
Leslie J Crofford
Nicole M Zaleski
Rebecca N Jerome
P2860
P304
P356
10.1089/ADT.2017.821
P577
2017-12-01T00:00:00Z